Medical Research and Clinical Trials

Revolutionizing Drug Development: Real-Time Clinical Trials Demand a Paradigm Shift in Supply Chain Management

• Medical Research and Clinical Trials

Revolutionizing Drug Development: Real-Time Clinical Trials Demand a Paradigm Shift in Supply Chain Management

Jia Lissa October 19, 2026

The traditional, batch-oriented approach to clinical trial data collection and analysis is undergoing a seismic shift with...

Read More Read more about Revolutionizing Drug Development: Real-Time Clinical Trials Demand a Paradigm Shift in Supply Chain Management

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Layla Zulfa October 19, 2026

NORMAN, OK – In a significant stride toward understanding and potentially combating one of the most aggressive...

Read More Read more about Groundbreaking Oklahoma Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

MacroGenics Initiates Landmark Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Initiates Landmark Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Suro Senen October 19, 2026

A pioneering study marks a significant step forward in the fight against difficult-to-treat cancers, offering new hope...

Read More Read more about MacroGenics Initiates Landmark Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Unmasking a Malignant Alliance: How Aggressive Breast Cancer Hijacks the Immune System to Fuel its Growth

• Medical Research and Clinical Trials

Unmasking a Malignant Alliance: How Aggressive Breast Cancer Hijacks the Immune System to Fuel its Growth

Evan Lee Salim October 18, 2026

NORMAN, OK – In a significant breakthrough that could redefine future cancer therapies, new research from the...

Read More Read more about Unmasking a Malignant Alliance: How Aggressive Breast Cancer Hijacks the Immune System to Fuel its Growth

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Rifan Muazin October 18, 2026

A significant step forward in the fight against difficult-to-treat cancers, US-based biopharmaceutical company MacroGenics has announced the...

Read More Read more about MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Asep Darmawan October 18, 2026

Oklahoma City, OK – In a significant stride for cancer research, scientists at the University of Oklahoma...

Read More Read more about Breakthrough Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Sagoh October 18, 2026

A pioneering investigational therapy, MGC030, developed by US-based biopharmaceutical company MacroGenics, has reached a significant milestone with...

Read More Read more about MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Ammar Sabilarrohman October 18, 2026

Norman, OK – In a significant stride toward understanding and potentially overcoming one of the most formidable...

Read More Read more about Groundbreaking Oklahoma Research Unveils How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

• Medical Research and Clinical Trials

MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Nila Kartika Wati October 18, 2026

A pioneering clinical trial has commenced, marking a significant step forward in the development of MGC030, an...

Read More Read more about MacroGenics Initiates Phase I Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

• Medical Research and Clinical Trials

Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth

Layla Zulfa October 17, 2026

Norman, OK – In a significant stride towards understanding and potentially treating one of the most aggressive...

Read More Read more about Breakthrough Research Uncovers How Aggressive Breast Cancer Hijacks Immune System to Fuel Growth